Autobio Diagnostics Co., Ltd (SHA: 603658), a Chinese in-vitro diagnostics company, has entered into a partnership with China National Medical Device Co., Ltd, another domestic firm. The collaboration aims to capitalize on the strengths of both parties to jointly promote and apply high-quality domestic products, thereby expanding the scale of their respective operations. The partnership also seeks to advance the integration and expansion of SPD (Sterile Processing Department), industry, and model innovation between the two entities, contributing significantly to the growth of the medical device industry.
Autobio plans to establish a new circulation cooperation model with Sinopharm Medical Devices, deepening into cooperative initiatives in interdisciplinary collaboration, SPD, industry, and other areas. The partnership will enhance regional engagement, facilitate the exchange and sharing of market information and resources, and fully leverage the advantages of both companies to achieve mutually beneficial outcomes.- Flcube.com
